Rapid Screening of Blood Mitochondrial D310 and D315 Mutations in Breast Cancer Patients

F. Akter, S. H. Israfil, Mohammad Ali, A. Rouf, M. Alam, M. Rahman, G. Sultana
{"title":"Rapid Screening of Blood Mitochondrial D310 and D315 Mutations in Breast Cancer Patients","authors":"F. Akter, S. H. Israfil, Mohammad Ali, A. Rouf, M. Alam, M. Rahman, G. Sultana","doi":"10.12691/JCRT-8-1-1","DOIUrl":null,"url":null,"abstract":"Aims: 'Poly C' stretch extending from 303 to 315 nucleotide positions known as (D310) by GeneBank within the non-coding region HVR-II of mitochondrial DNA (mtDNA) has been identified as a mutational hotspot of primary cancer. We aimed to find this mutation in Bangladeshi breast cancer patients and control samples for screening the changes in poly C stretches. Materials and Methods: We have analyzed a total of 98 breast cancer blood samples and 98 healthy control blood samples and extracted DNA from blood samples for direct sequencing using ABI®3130 Genetic Analyzer. Results: We observed 70.41% C insertion at 310 regions (P<0.001, OR = 16.30 and 95% CI=7.83-33.93) in breast cancer patient whereas it is present only in 12.24% healthy individuals. No alterations were observed in 29.59% breast cancer samples. We also check the mutation pattern at D315 regions, but no significant observation was found (P=1.00). Conclusions: This is the first study from Bangladeshi breast cancer (BC) patients indicating a relatively high frequency of D310 mutations, which suggests that mtDNA instability at D310 may be a common characteristic of BC, study also supports the hypothesis that mtDNA D310 screening may represent additional blood based biomarker for breast cancer prognosis.","PeriodicalId":22619,"journal":{"name":"The Journal of Cancer Research","volume":"37 1","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Cancer Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12691/JCRT-8-1-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: 'Poly C' stretch extending from 303 to 315 nucleotide positions known as (D310) by GeneBank within the non-coding region HVR-II of mitochondrial DNA (mtDNA) has been identified as a mutational hotspot of primary cancer. We aimed to find this mutation in Bangladeshi breast cancer patients and control samples for screening the changes in poly C stretches. Materials and Methods: We have analyzed a total of 98 breast cancer blood samples and 98 healthy control blood samples and extracted DNA from blood samples for direct sequencing using ABI®3130 Genetic Analyzer. Results: We observed 70.41% C insertion at 310 regions (P<0.001, OR = 16.30 and 95% CI=7.83-33.93) in breast cancer patient whereas it is present only in 12.24% healthy individuals. No alterations were observed in 29.59% breast cancer samples. We also check the mutation pattern at D315 regions, but no significant observation was found (P=1.00). Conclusions: This is the first study from Bangladeshi breast cancer (BC) patients indicating a relatively high frequency of D310 mutations, which suggests that mtDNA instability at D310 may be a common characteristic of BC, study also supports the hypothesis that mtDNA D310 screening may represent additional blood based biomarker for breast cancer prognosis.
乳腺癌患者血线粒体D310和D315突变的快速筛选
目的:在线粒体DNA (mtDNA)的非编码区HVR-II中,从303到315个核苷酸位置的“Poly C”延伸(D310)已被GeneBank确定为原发性癌症的突变热点。我们的目的是在孟加拉国乳腺癌患者和对照样本中发现这种突变,以筛选聚C延伸的变化。材料和方法:我们共分析了98份乳腺癌血液样本和98份健康对照血液样本,并从血液样本中提取DNA,使用ABI®3130基因分析仪进行直接测序。结果:我们在乳腺癌患者中观察到70.41%的310个区域的C插入(P<0.001, OR = 16.30, 95% CI=7.83-33.93),而在健康人群中仅存在12.24%。在29.59%的乳腺癌样本中未观察到任何改变。我们还检查了D315区域的突变模式,但没有发现显著的变化(P=1.00)。结论:这是第一个来自孟加拉国乳腺癌(BC)患者的研究,表明D310突变频率相对较高,这表明D310 mtDNA不稳定可能是BC的共同特征,研究还支持mtDNA D310筛查可能代表乳腺癌预后的额外血液生物标志物的假设。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信